Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05548933
Other study ID # 2022-0567
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 20, 2022
Est. completion date November 1, 2023

Study information

Verified date September 2022
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact Yanmin Wu
Phone +86 137 5711 9560
Email wuyanmin@zju.edu.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study was a single-center, non-randomized, parallel-group design clinical trial, and each group was assigned a 1:1 ratio with or without hyperlipidemia. Both groups underwent periodontal non-surgical treatment, and blood and gingival crevicular fluid were collected before surgery, 1 month and 3 months after surgery for the detection of MCP-1, IL-8, oxLDL, TNF-α, TG, LDL-C, HDL-C.


Description:

This study was a single-center, non-randomized, parallel-group design clinical trial, and each group was assigned a 1:1 ratio with or without hyperlipidemia. Both groups underwent periodontal non-surgical treatment, and blood and gingival crevicular fluid were collected before surgery, 1 month and 3 months after surgery for the detection of MCP-1, IL-8, oxLDL, TNF-α, TG, LDL-C, HDL-C.MCP-1, IL-8, oxLDL, TNF-α will be tested for concentration using ELISA.


Recruitment information / eligibility

Status Recruiting
Enrollment 64
Est. completion date November 1, 2023
Est. primary completion date November 1, 2023
Accepts healthy volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Subjects had to meet at least one of the following criteria for the diagnosis of hyperlipidemia: triglyceride (TRG) levels >2.26 mmol/L; high density lipoprotein cholesterol (HDL-C) levels <1.04 mmol/L; or low density lipoprotein cholesterol (LDL-C) levels >4.14 mmol/L - Patients with severe periodontitis (stage III/IV) with probing depth (PD) = 6 mm at at least six sites, at least two multi-rooted or two single-rooted teeth in at least one quadrant, and extended bone loss on imaging to the middle or top third of the root. Periodontitis results in the loss of less than or equal to four teeth. Exclusion Criteria: - systemic illnesses - pregnancy or lactation - systemic antibiotics taken within the previous 6 months - use of cholesterol reduction medication during the past 6 months - subgingival scaling and root planing or surgical periodontal therapy in the last year - chewing smokeless tobacco, smoking pipes or cigars 1 or more times per week, or smoking more than 20 cigarettes per week (1 pack per week) in the past 6 months

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
non-surgical periodontal therapy
supragingival scaling,subgingival scaling

Locations

Country Name City State
China 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou Zhejiang

Sponsors (1)

Lead Sponsor Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary monocyte chemotactic protein-1,MCP-1 Concentration of MCP-1 in gingival crevicular fluids Before surgery
Primary monocyte chemotactic protein-1,MCP-1 Concentration of MCP-1 in gingival crevicular fluids 1 month after surgery
Primary monocyte chemotactic protein-1,MCP-1 Concentration of MCP-1 in gingival crevicular fluids 3 months after surgery
Primary oxidized low-density lipoprotein cholesterol, oxLDL Concentration of oxLDL in gingival crevicular fluids and serum Before surgery
Primary oxidized low-density lipoprotein cholesterol, oxLDL Concentration of oxLDL in gingival crevicular fluids and serum 1 month after surgery
Primary oxidized low-density lipoprotein cholesterol, oxLDL Concentration of oxLDL in gingival crevicular fluids and serum 3 months after surgery
Secondary interleukin-8,IL-8 Concentration of IL-8 in gingival crevicular fluids Before surgery
Secondary interleukin-8,IL-8 Concentration of IL-8 in gingival crevicular fluids 1 month after surgery
Secondary interleukin-8,IL-8 Concentration of IL-8 in gingival crevicular fluids 3 months after surgery
Secondary triglycerides,TG Concentration of TG in serum Before surgery
Secondary triglycerides,TG Concentration of TG in serum 1 month after surgery
Secondary triglycerides,TG Concentration of TG in serum 3 months after surgery
Secondary low-density lipoprotein cholesterol,LDL-C Concentration of LDL-C in serum Before surgery
Secondary low-density lipoprotein cholesterol,LDL-C Concentration of LDL-C in serum 1 month after surgery
Secondary low-density lipoprotein cholesterol,LDL-C Concentration of LDL-C in serum 3 months after surgery
Secondary high-density lipoprotein cholesterol,HDL-C Concentration of HDL-C in serum Before surgery
Secondary high-density lipoprotein cholesterol,HDL-C Concentration of HDL-C in serum 1 month after surgery
Secondary high-density lipoprotein cholesterol,HDL-C Concentration of HDL-C in serum 3 months after surgery
Secondary probing depth,PD The distance (mm) from the bottom of the periodontal pocket to the gingival margin was measured with a periodontal probe (UNC-15, Hu-Friedy, Chicago, IL) parallel to the long axis of the tooth. The mesial, median and distal 6 sites of the labial (buccal) and lingual surfaces were recorded for each tooth. Before surgery
Secondary probing depth,PD The distance (mm) from the bottom of the periodontal pocket to the gingival margin was measured with a periodontal probe (UNC-15, Hu-Friedy, Chicago, IL) parallel to the long axis of the tooth. The mesial, median and distal 6 sites of the labial (buccal) and lingual surfaces were recorded for each tooth. 1 month after surgery
Secondary probing depth,PD The distance (mm) from the bottom of the periodontal pocket to the gingival margin was measured with a periodontal probe (UNC-15, Hu-Friedy, Chicago, IL) parallel to the long axis of the tooth. The mesial, median and distal 6 sites of the labial (buccal) and lingual surfaces were recorded for each tooth. 3 months after surgery
Secondary clinical attachment level,CAL The periodontal probe measures the distance (mm) from the bottom of the gingival sulcus or the bottom of the periodontal pocket to the cementoenamel boundary. The mesial, median and distal 6 points of the labial (buccal) and lingual surfaces were recorded for each tooth. Before surgery
Secondary clinical attachment level,CAL The periodontal probe measures the distance (mm) from the bottom of the gingival sulcus or the bottom of the periodontal pocket to the cementoenamel boundary. The mesial, median and distal 6 points of the labial (buccal) and lingual surfaces were recorded for each tooth. 1 month after surgery
Secondary clinical attachment level,CAL The periodontal probe measures the distance (mm) from the bottom of the gingival sulcus or the bottom of the periodontal pocket to the cementoenamel boundary. The mesial, median and distal 6 points of the labial (buccal) and lingual surfaces were recorded for each tooth. 3 months after surgery
Secondary percentage of bleeding on probing,BOP% Gently probe to the bottom of the bag or gingival sulcus, take out the probe and observe for 10-15 seconds to see if there is any bleeding. The mesial, median and distal 6 sites of the labial (buccal) and lingual surfaces were recorded for each tooth. Calculate the percentage of bleeding sites. Before surgery
Secondary percentage of bleeding on probing,BOP% Gently probe to the bottom of the bag or gingival sulcus, take out the probe and observe for 10-15 seconds to see if there is any bleeding. The mesial, median and distal 6 sites of the labial (buccal) and lingual surfaces were recorded for each tooth. Calculate the percentage of bleeding sites. 1 month after surgery
Secondary percentage of bleeding on probing,BOP% Gently probe to the bottom of the bag or gingival sulcus, take out the probe and observe for 10-15 seconds to see if there is any bleeding. The mesial, median and distal 6 sites of the labial (buccal) and lingual surfaces were recorded for each tooth. Calculate the percentage of bleeding sites. 3 months after surgery
See also
  Status Clinical Trial Phase
Completed NCT00001154 - Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
Completed NCT02927184 - Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease Phase 2
Completed NCT04640012 - Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics of DC371739 Single-Dose Treatment in Healthy Subjects Phase 1
Completed NCT03213288 - Bilberry Fruit and Black Rice Derived Anthocyanins on Lipid Status N/A
Completed NCT00382564 - Magnetic Resonance Angiography to Diagnose Atherosclerotic Disease N/A
Recruiting NCT02979704 - A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia Phase 2/Phase 3
Completed NCT02569814 - A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin Phase 1
Completed NCT02280590 - Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia Phase 4
Completed NCT02428998 - Safety for 24 Weeks Intake of Korean Red Ginseng in Adults N/A
Completed NCT01678183 - Financial Incentives for Medication Adherence N/A
Completed NCT01426412 - A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol Phase 1
Completed NCT01694446 - Regulation of Intestinal and Hepatic Lipoprotein Production by Glucose and Fructose N/A
Completed NCT01131832 - Genetic Basis for Heterogeneity in Response of Plasma Lipids to Plant Sterols Phase 4
Completed NCT00534105 - Lipid Metabolism in Gestational Diabetes N/A
Completed NCT00758303 - A Study to Evaluate the Lipid Regulating Effects of TRIA-662 Phase 2/Phase 3
Recruiting NCT00408824 - Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study) N/A
Terminated NCT00299169 - Randomized Trial Comparing N of 1 Trials to Standard Practice to Improve Adherence to Statins in Patients With Diabetes Phase 4
Completed NCT00362206 - Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin Phase 3
Completed NCT00381992 - Risk Assessment of Long-Haul Truck Drivers N/A
Completed NCT00701454 - Survey of Thai-Muslim Health Status N/A